Zions Bancorporation N.A. Purchases 1,618 Shares of KKR & Co. Inc. (NYSE:KKR)

Zions Bancorporation N.A. boosted its position in shares of KKR & Co. Inc. (NYSE:KKR) by 21.4% in the fourth quarter, Holdings Channel reports. The firm owned 9,195 shares of the asset manager’s stock after purchasing an additional 1,618 shares during the period. Zions Bancorporation N.A.’s holdings in KKR & Co. Inc. were worth $1,360,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Farmers & Merchants Investments Inc. boosted its position in shares of KKR & Co. Inc. by 17.8% during the fourth quarter. Farmers & Merchants Investments Inc. now owns 430 shares of the asset manager’s stock worth $64,000 after purchasing an additional 65 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in KKR & Co. Inc. by 0.4% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 16,427 shares of the asset manager’s stock worth $2,430,000 after buying an additional 69 shares during the period. Ballentine Partners LLC lifted its holdings in KKR & Co. Inc. by 1.2% during the fourth quarter. Ballentine Partners LLC now owns 5,721 shares of the asset manager’s stock worth $846,000 after acquiring an additional 70 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in KKR & Co. Inc. by 5.7% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,289 shares of the asset manager’s stock valued at $191,000 after acquiring an additional 70 shares during the period. Finally, Wealthcare Advisory Partners LLC increased its holdings in shares of KKR & Co. Inc. by 0.7% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 10,974 shares of the asset manager’s stock worth $1,623,000 after acquiring an additional 73 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Stock Up 0.2 %

KKR stock opened at $122.27 on Wednesday. The company has a market cap of $108.61 billion, a price-to-earnings ratio of 36.72, a P/E/G ratio of 1.00 and a beta of 1.72. KKR & Co. Inc. has a twelve month low of $91.92 and a twelve month high of $170.40. The business has a 50 day moving average price of $138.26 and a two-hundred day moving average price of $141.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.82.

KKR & Co. Inc. Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a $0.175 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.70 annualized dividend and a dividend yield of 0.57%. KKR & Co. Inc.’s dividend payout ratio is presently 21.02%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on KKR shares. Keefe, Bruyette & Woods cut their price objective on KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating on the stock in a report on Monday, January 13th. HSBC lowered shares of KKR & Co. Inc. from a “buy” rating to a “hold” rating and lifted their price target for the company from $153.00 to $173.00 in a research note on Thursday, January 30th. Morgan Stanley lowered their price objective on shares of KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research report on Thursday, February 6th. Hsbc Global Res cut shares of KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 30th. Finally, Oppenheimer upped their target price on shares of KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a research note on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, KKR & Co. Inc. currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.79.

Insider Buying and Selling

In related news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the firm’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total value of $197,760,000.00. Following the completion of the sale, the insider now directly owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. This trade represents a 23.75 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 39.34% of the stock is owned by corporate insiders.

KKR & Co. Inc. Company Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.